Neuroinflammation from aberrantly activated glia is reemerging as an important mechanism that contributes to AD progression involving TNF-α, cyclooxygenase-2 (COX-2), and interleukin 6 (IL-6) amongst others [15,16]. Here, PTGS2 is linked to Alzheimer disease.